Anti-CD39 mAbs licensed to Innate Pharma
Target Discovery Program
R&D engineer – In vivo [closed]
R&D Engineer [closed]
R&D engineer – in vivo [closed]
R&D Engineer – in vivo [closed]
R&D engineer [closed]
IL-17B program to be presented at AACR 2017
AACR 2017 Meeting, Washington DC, April 1-5
and Happy New Year 2017 !
IL-17 interleukins & resistance to EGFR therapies
2 publications from J. Giustiniani and colleagues.
See all news
OREGA Biotech wishes you a Merry Christmas and a Happy New Year 2017 !
See all our news
Meet us at AACR meeting 2017
Washington DC, April 1-5, 2017
Meet us at Bio-Europe Spring 2017
Barcelona, March 20-22, 2017
Meet2Win 2016 event
Jeremy Bastid, COO, will attend the Meet2Win event in Bordeaux, May 12 & 13.
See all events